en
Scientific article
English

Long-term outcomes of elderly patients with CYP2C9 and VKORC1 variants treated with vitamin K antagonists

Published inJournal of Thrombosis and Haemostasis, vol. 15, p. 2165-2175
Publication date2017
Abstract

The long-term effect of polymorphisms of the vitamin K-epoxide reductase (VKORC1) and the cytochrome P450 enzyme gene (CYP2C9) on clinical outcomes remains unclear.

Citation (ISO format)
NAGLER, M et al. Long-term outcomes of elderly patients with CYP2C9 and VKORC1 variants treated with vitamin K antagonists. In: Journal of Thrombosis and Haemostasis, 2017, vol. 15, p. 2165–2175. doi: 10.1111/jth.13810
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal1538-7836
389views
0downloads

Technical informations

Creation08/30/2017 12:27:00 PM
First validation08/30/2017 12:27:00 PM
Update time03/15/2023 2:24:17 AM
Status update03/15/2023 2:24:17 AM
Last indexation01/17/2024 1:27:16 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack